ClinicalTrials.Veeva

Menu

BrightPoint Reflectometer Device Study

University Hospitals (UH) logo

University Hospitals (UH)

Status

Completed

Conditions

Epidural Placement

Treatments

Device: BrightPoint

Study type

Interventional

Funder types

Other

Identifiers

NCT05616299
STUDY20220677

Details and patient eligibility

About

Participants are being asked to participate in this study because they are having an epidural placed for labor. This human clinical trial has been designed to evaluate the use of the BrightPoint Reflectometer Device (AKA BrightPoint device) as secondary confirmation of Loss of Residence (LOR) for lumbar epidural placement by an experienced clinician. For this study, participants will be randomized to receive an epidural by an experienced clinician either with or without the use of the BrightPoint device. Epidurals performed as a part of this study will be done in a manner similar to how epidurals are currently performed in the hospital. The epidural space will be entered using usual loss of resistance technique for all patients. If the BrightPoint device is used, it will be as secondary verification of entry into the epidural space.

Enrollment

3 patients

Sex

Female

Ages

18 to 79 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Any patient undergoing an epidural procedure

Exclusion criteria

  • Previous lumbar spine surgery
  • Any known spinal abnormality that would interferre with successfully advancing a needle into the epidural space
  • Any subject that requires an epidural needle longer than 4.0 inches
  • Any procedure requiring use of CSE needles
  • Any contraindication to neuraxial anesthesia
  • No subjects in advanced active labor, e.g., 6-8 cm dilated
  • Tattoo at the site of epidural insertion

Trial design

Primary purpose

Device Feasibility

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3 participants in 2 patient groups

BrightPoint Epidural
Experimental group
Description:
Subjects will receive an epidural using the BrightPoint device concurrent with usual LOR technique using the same epidural needle, sterile saline, syringe, etc.
Treatment:
Device: BrightPoint
Normal Epidural
No Intervention group
Description:
Subjects will have an epidural placed in usual manner with LOR technique using the same epidural needle, sterile saline, syringe etc. but without use of the BrightPoint device.

Trial contacts and locations

1

Loading...

Central trial contact

Mary Consolo; Hayley Groubert

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems